SCHEMBL18028120

SCHEMBL18028120

O=C1CCN1c1ccc(N2CCC=C(N3CCOCC3)C2=O)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.42
▸ HPGD P15428 1/20 0.42
▸ KMT2A Q03164 3/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ TSHR P16473 1/20 0.36
▸ EP300 Q09472 1/20 0.35
▸ KAT2B Q92831 1/20 0.35
▸ RAD51 Q06609 1/20 0.35
▸ MEN1 O00255 2/20 0.35
▸ APAF1 O14727 1/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ TDP2 O95551 1/20 0.35
▸ NSD2 O96028 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ GALK1 P51570 1/20 0.35
▸ BLM P54132 1/20 0.35
▸ ATM Q13315 1/20 0.35
▸ HKDC1 Q2TB90 1/20 0.35
▸ NOD2 Q9HC29 1/20 0.35
▸ ATG4B Q9Y4P1 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16730262 0.92 ALDH1A1 (0.52) ALDH1A1HPGDKMT2AKDM4ETSHR
SCHEMBL5444324 0.91 ALDH1A1 (0.48) ALDH1A1HPGDKMT2AKDM4ETSHR
SCHEMBL15628318 0.88 F10 (0.47) F10PTGS2
SCHEMBL15731795 0.86 PIK3R1 (0.39) ALDH1A1KMT2AKDM4EEP300KAT2B
SCHEMBL20050092 0.84 ALDH1A1 (0.42) ALDH1A1KMT2AKDM4ETSHREP300
SCHEMBL29483984 0.84 RAD51 (0.51) KMT2ATSHRRAD51MEN1MAPT
SCHEMBL17576245 0.84 AKR1C3 (0.44) ALDH1A1HPGDKMT2AKDM4EMEN1
SCHEMBL1919863 0.84 AKR1C3 (0.44) ALDH1A1KMT2AEP300KAT2BRAD51
SCHEMBL6330031 0.84 KMT2A (0.49) ALDH1A1KMT2AKDM4ERAD51MEN1
SCHEMBL186752 0.84 LMNA (0.51) ALDH1A1HPGDKMT2ATSHRRAD51

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9815833-B2 Pyridine derivative and medical use thereof CHENGDU EASTON BIOPHARMACEUTICALS CO., LTD. (CN) 2017-11-14 — — US disclosed
US-20160244440-A1 PYRIDINE DERIVATIVE AND MEDICAL USE THEREOF Zhejiang Yatai Pharmaceutical Co., Ltd. (CN) 2016-08-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160244440-A1 PYRIDINE DERIVATIVE AND MEDICAL USE THEREOF PEPD, F2, XDH ALDH1A1 905/4885HPGD 42/4885KMT2A 3593/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback